Your browser doesn't support javascript.
loading
Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
Serrano-Villar, Sergio; Sainz, Talia; Ma, Zhong-Min; Utay, Netanya S; Chun, Tae-Wook; Wook-Chun, Tae; Mann, Surinder; Kashuba, Angela D; Siewe, Basile; Albanese, Anthony; Troia-Cancio, Paolo; Sinclair, Elizabeth; Somasunderam, Anoma; Yotter, Tammy; Deeks, Steven G; Landay, Alan; Pollard, Richard B; Miller, Christopher J; Moreno, Santiago; Asmuth, David M.
Afiliación
  • Serrano-Villar S; University Hospital Ramón y Cajal, Madrid, Spain.
  • Sainz T; University Hospital La Paz, Madrid, Spain.
  • Ma ZM; California National Primate Research Center, Davis, California, United States of America.
  • Utay NS; University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Wook-Chun T; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
  • Mann S; University of California Davis Medical Center, Sacramento, California, United States of America.
  • Kashuba AD; University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.
  • Siewe B; Rush University, Chicago, Illinois, United States of America.
  • Albanese A; Veterans Administration Northern California Health Care System, Mather, California, United States of America.
  • Troia-Cancio P; University of California Davis Medical Center, Sacramento, California, United States of America.
  • Sinclair E; University of California San Francisco, San Francisco, California, United States of America.
  • Somasunderam A; University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Yotter T; University of California Davis Medical Center, Sacramento, California, United States of America.
  • Deeks SG; University of California San Francisco, San Francisco, California, United States of America.
  • Landay A; Rush University, Chicago, Illinois, United States of America.
  • Pollard RB; University of California Davis Medical Center, Sacramento, California, United States of America.
  • Miller CJ; California National Primate Research Center, Davis, California, United States of America.
  • Moreno S; University of California Davis Medical Center, Sacramento, California, United States of America.
  • Asmuth DM; University Hospital Ramón y Cajal, Madrid, Spain.
PLoS Pathog ; 12(1): e1005381, 2016 Jan.
Article en En | MEDLINE | ID: mdl-26795282
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_enfermedades_transmissibles Asunto principal: Infecciones por VIH / Subgrupos de Linfocitos T / Inmunidad Mucosa / Inhibidores de Integrasa VIH / Antagonistas de los Receptores CCR5 Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: PLoS Pathog Año: 2016 Tipo del documento: Article País de afiliación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_enfermedades_transmissibles Asunto principal: Infecciones por VIH / Subgrupos de Linfocitos T / Inmunidad Mucosa / Inhibidores de Integrasa VIH / Antagonistas de los Receptores CCR5 Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: PLoS Pathog Año: 2016 Tipo del documento: Article País de afiliación: España